Clinical Trials Logo
  1. Home
  2. Hypotrichosis
  3. NCT00958035

Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis

Hypotrichosis Clinical Trial

Clinical Trial Summary

This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily to the upper eyelid margins (where the eyelashes meet the skin) compared with vehicle in increasing overall eyelash prominence in self-identified African American/ethnic black subjects exhibiting hypotrichosis of the eyelashes (inadequate or not enough eyelashes).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00958035
Study type Interventional
Source Allergan
Contact
Status Completed
Phase Phase 4
Start date November 2009
Completion date August 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT01448525 - Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence Phase 4
Completed NCT01891487 - Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows Phase 4
Completed NCT01387906 - Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo Phase 4
Recruiting NCT05790941 - Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation Early Phase 1
Recruiting NCT05723198 - A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata Phase 3
Completed NCT01200251 - Study of Bimatoprost Gel on Eyelash Growth Phase 3
Completed NCT00907426 - Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin Phase 3